Corner Therapeutics
Cambridge, United States· Est.
Corner Therapeutics is developing targeted immunotherapies to treat cancer and autoimmune diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $54M
About
Corner Therapeutics is developing targeted immunotherapies to treat cancer and autoimmune diseases.
OncologyImmunology
Funding History
1Total raised:$54M
Series A$54M